參考文獻 |
1. Sampson, H. A.; Muñoz-Furlong, A.; Campbell, R. L.; Adkinson Jr, N. F.; Bock, S. A.; Branum, A.; Brown, S. G.; Camargo Jr, C. A.; Cydulka, R.; Galli, S. J., Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Journal of Allergy and Clinical Immunology 2006, 117 (2), 391-397.
2. Lieberman, P.; Camargo, C. A.; Bohlke, K.; Jick, H.; Miller, R. L.; Sheikh, A.; Simons, F. E. R., Epidemiology of anaphylaxis: findings of the American college of allergy, asthma and immunology epidemiology of anaphylaxis working group. Annals of Allergy, Asthma & Immunology 2006, 97 (5), 596-602.
3. Tejedor Alonso, M.; Moro Moro, M.; Múgica García, M., Epidemiology of anaphylaxis. Clinical & Experimental Allergy 2015, 45 (6), 1027-1039.
4. Motosue, M. S.; Bellolio, M. F.; Van Houten, H. K.; Shah, N. D.; Campbell, R. L., Increasing emergency department visits for anaphylaxis, 2005-2014. The Journal of Allergy and Clinical Immunology: In Practice 2017, 5 (1), 171-175. e3.
5. Hsin, Y.-C.; Hsin, Y.-C.; Huang, J.-L.; Yeh, K.-W., Clinical features of adult and pediatric anaphylaxis in Taiwan. Asian Pac J Allergy Immunol 2011, 29 (4), 307-312.
6. Nel, L.; Eren, E., Peri‐operative anaphylaxis. British journal of clinical pharmacology 2011, 71 (5), 647-658.
7. 梁汝安. 利用嗜鹼性白血球致敏化試驗探討IgE在藥物引發第一型過敏反應之角色. 國立陽明大學, 台北市, 2015.
8. Kemp, S. F.; Lockey, R. F., Anaphylaxis: a review of causes and mechanisms. Journal of allergy and clinical immunology 2002, 110 (3), 341-348.
9. Gell, P. G. H.; Coombs, R. R. A., Clinical aspects of immunology. Clinical Aspects of Immunology. 1963.
10. Gould, H. J.; Sutton, B. J.; Beavil, A. J.; Beavil, R. L.; McCloskey, N.; Coker, H. A.; Fear, D.; Smurthwaite, L., The biology of IGE and the basis of allergic disease. Annual review of immunology 2003, 21 (1), 579-628.
11. Capra, J. D.; Janeway, C. A.; Travers, P.; Walport, M., Inmunobiology: the inmune system in health and disease. Garland Publishing: 1999.
12. Galli, S. J.; Tsai, M., IgE and mast cells in allergic disease. Nature medicine 2012, 18 (5), 693.
13. MacGlashan Jr, D., IgE receptor and signal transduction in mast cells and basophils. Current opinion in immunology 2008, 20 (6), 717-723.
14. Bax, H. J.; Keeble, A. H.; Gould, H. J., Cytokinergic IgE action in mast cell activation. Frontiers in immunology 2012, 3, 229.
15. Lagopoulos, V.; Gigi, E., Anaphylactic and anaphylactoid reactions during the perioperative period. Hippokratia 2011, 15 (2), 138.
16. Ring, J.; Behrendt, H., Anaphylaxis and anaphylactoid reactions. Clinical reviews in allergy & immunology 1999, 17 (4), 387-399.
17. Hypersensitivities | Microbiology - Lumen Learning. https://courses.lumenlearning.com/microbiology/chapter/hypersensitivities/.
18. jessica36 https://www.memorangapp.com/flashcards/151368/Step+1+Immuno/.
19. Mayorga, C.; Sanz, M.; Gamboa, P.; García, B.; Caballero, M.; Garcia, J.; Labrador, M.; Lahoz, C.; Areso, N. L.; Hoyos, M. L., In vitro diagnosis of immediate allergic reactions to drugs: an update. J Investig Allergol Clin Immunol 2010, 20 (2), 103-109.
20. Brockow, K.; Romano, A.; Blanca, M.; Ring, J.; Pichler, W.; Demoly, P., General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002, 57 (1), 45-51.
21. Zambonino, M. A.; Torres, M. J.; Muñoz, C.; Requena, G.; Mayorga, C.; Posadas, T.; Urda, A.; Blanca, M.; Corzo, J. L., Drug provocation tests in the diagnosis of hypersensitivity reactions to non‐steroidal anti‐inflammatory drugs in children. Pediatric Allergy and Immunology 2013, 24 (2), 151-159.
22. Aberer, W.; Kränke, B., Provocation tests in drug hypersensitivity. Immunology and allergy clinics of North America 2009, 29 (3), 567-584.
23. Aberer, W.; Bircher, A.; Romano, A.; Blanca, M.; Campi, P.; Fernandez, J.; Brockow, K.; Pichler, W. J.; Demoly, P.; ENDA, Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003, 58 (9), 854-863.
24. Lebel, B.; Messaad, D.; Kvedariene, V.; Rongier, M.; Bousquet, J.; Demoly, P., Cysteinyl‐leukotriene release test (CAST) in the diagnosis of immediate drug reactions. Allergy 2001, 56 (7), 688-692.
25. Romano, A.; Torres, M. J.; Castells, M.; Sanz, M. L.; Blanca, M., Diagnosis and management of drug hypersensitivity reactions. Journal of Allergy and Clinical Immunology 2011, 127 (3), S67-S73.
26. Kim, M. S.; Cho, Y. J., Flow cytometry-assisted basophil activation test as a safe diagnostic tool for aspirin/NSAID hypersenstivity. Allergy, asthma & immunology research 2012, 4 (3), 137-142.
27. https://en.wikipedia.org/wiki/B-cell_receptor.
28. Vervloet, D.; Magnan, A.; Birnbaum, J.; Pradal, M., Allergic emergencies seen in surgical suites. Clinical reviews in allergy & immunology 1999, 17 (4), 459.
29. Laxenaire, M.; Mertes, P.; des Réactions Anaphylactoïdes, G. d. E., Anaphylaxis during anaesthesia. Results of a two‐year survey in France. British Journal of Anaesthesia 2001, 87 (4), 549-558.
30. Fisher, M.; Baldo, B., Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention. European journal of anaesthesiology 1994, 11 (4), 263.
31. Harboe, T.; Guttormsen, A. B.; Irgens, A.; Dybendal, T.; Florvaag, E., Anaphylaxis during Anesthesia in NorwayA 6-Year Single-center Follow-up Study. Anesthesiology: The Journal of the American Society of Anesthesiologists 2005, 102 (5), 897-903.
32. Escolano, F.; Valero, A.; Huguet, J.; Baxarias, P.; Castro, A.; Granel, C.; Sanosa, J.; Bartolomé, B., Prospective epidemiologic study of perioperative anaphylactoid reactions occurring in Catalonia (1996-7). Revista espanola de anestesiologia y reanimacion 2002, 49 (6), 286-293.
33. Moneret-Vautrin, A.; Mertes, P. M., Anaphylaxis to general anesthetics. In Anaphylaxis, Karger Publishers: 2010; Vol. 95, pp 180-189.
34. Hepner, D. L.; Castells, M. C., Anaphylaxis during the perioperative period. Anesthesia & Analgesia 2003, 97 (5), 1381-1395.
35. Didier, A.; Cador, D.; Bongrand, P.; Furstoss, R.; Fourneron, P.; Senft, M.; Philip-Joet, F.; Charpin, D.; Charpin, J.; Vervloet, D., Role of the quaternary ammonium ion determinants in allergy to muscle relaxants. Journal of allergy and clinical immunology 1987, 79 (4), 578-584.
36. Baldo, B.; Fisher, M.; Pham, N., On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective. Clinical & Experimental Allergy 2009, 39 (3), 325-344.
37. Koppert, W.; Blunk, J. A.; Petersen, L. J.; Skov, P.; Rentsch, K.; Schmelz, M., Different patterns of mast cell activation by muscle relaxants in human skin. Anesthesiology: The Journal of the American Society of Anesthesiologists 2001, 95 (3), 659-667.
38. Mertes, P.; Laxenaire, M. In Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001-December 2002), Annales francaises d′anesthesie et de reanimation, 2004; pp 1133-1143.
39. Kroigaard, M.; Garvey, L.; Gillberg, L.; Johansson, S.; Mosbech, H.; Florvaag, E.; Harboe, T.; Eriksson, L.; Dahlgren, G.; Seeman‐Lodding, H., Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow‐up of anaphylaxis during anaesthesia. Acta anaesthesiologica scandinavica 2007, 51 (6), 655-670.
40. Party, M. o. t. W.; Harper, N.; Dixon, T.; Dugué, P.; Edgar, D.; Fay, A.; Gooi, H.; Herriot, R.; Hopkins, P.; Hunter, J., Suspected Anaphylactic Reactions Associated with Anaesthesia: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia 2009, 64 (2), 199-211.
41. Ebo, D.; Fisher, M.; Hagendorens, M.; Bridts, C.; Stevens, W., Anaphylaxis during anaesthesia: diagnostic approach. Allergy 2007, 62 (5), 471-487.
42. Norred, C. L., Anesthetic-induced anaphylaxis. AANA journal 2012, 80 (2).
43. Bennett, M. J.; Anderson, L. K.; McMillan, J. C.; Ebertz, J. M.; Hanifin, J. M.; Hirshman, C. A., Anaphylactic reaction during anaesthesia associated with positive intradermal skin test to fentanyl. Canadian Anaesthetists’ Society Journal 1986, 33 (1), 75-78.
44. Ebo, D.; Bridts, C.; Hagendorens, M.; Aerts, N.; De Clerck, L.; Stevens, W., Basophil activation test by flow cytometry: present and future applications in allergology. Cytometry Part B: Clinical Cytometry 2008, 74 (4), 201-210.
45. Hausmann, O. V.; Gentinetta, T.; Bridts, C. H.; Ebo, D. G., The basophil activation test in immediate-type drug allergy. Immunology and allergy clinics of North America 2009, 29 (3), 555-566.
46. Mayes, S.; Ferrone, M., Fentanyl HCl Patient-Controlled lontophoretic Transdermal System for the Management of Acute Postoperative Pain. Annals of Pharmacotherapy 2006, 40 (12), 2178-2186.
47. Higashikawa, Y.; Suzuki, S., Studies on 1-(2-phenethyl)-4-(N-propionylanilino) piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues. Forensic Toxicology 2008, 26 (1), 1-5.
48. Vardanyan, R. S.; Hruby, V. J., Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications. Future medicinal chemistry 2014, 6 (4), 385-412.
49. Galzi, J.; Ilien, B.; Simon, E.; Goeldner, M.; Hirth, C., Marquage irreversible des recepteurs des opioides a l′aide de sels d′aryldiazonium derives du fentanyl. Tetrahedron letters 1987, 28 (4), 401-404.
50. Sanz, M.; Gamboa, P.; Antepara, I.; Uasuf, C.; Vila, L.; Garcia‐Aviles, C.; Chazot, M.; De Weck, A., Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate‐type reactions to betalactam antibiotics. Clinical & Experimental Allergy 2002, 32 (2), 277-286.
51. Fuster, M. M.; Esko, J. D., The sweet and sour of cancer: glycans as novel therapeutic targets. Nature Reviews Cancer 2005, 5 (7), 526.
52. Lu, D.-Y.; Lu, T.-R.; Wu, H.-Y., Development of antimetastatic drugs by targeting tumor sialic acids. Scientia pharmaceutica 2012, 80 (3), 497.
53. Wikipedia contributors Sialic acid. https://en.wikipedia.org/w/index.php?title=Sialic_acid&oldid=851653909 (accessed 8 September 2018 09:08 UTC).
54. Weijers, C. A.; Franssen, M. C.; Visser, G. M., Glycosyltransferase-catalyzed synthesis of bioactive oligosaccharides. Biotechnology advances 2008, 26 (5), 436-456.
55. Boons, G.-J.; Demchenko, A. V., Recent advances in O-sialylation. Chemical reviews 2000, 100 (12), 4539-4566.
56. Lazniewski, M.; Dawson, W. K.; Szczepińska, T.; Plewczynski, D., The structural variability of the influenza A hemagglutinin receptor-binding site. Briefings in functional genomics 2017.
57. Varki, A.; Schauer, R., Sialic acids. 2009.
58. Cabral, M. G.; Piteira, A. R.; Silva, Z.; Ligeiro, D.; Brossmer, R.; Videira, P. A., Human dendritic cells contain cell surface sialyltransferase activity. Immunology letters 2010, 131 (1), 89-96.
59. Varki, A., Sialic acids in human health and disease. Trends in molecular medicine 2008, 14 (8), 351-360.
60. Wang, B.; Brand-Miller, J., The role and potential of sialic acid in human nutrition. European journal of clinical nutrition 2003, 57 (11), 1351.
61. Vajaria, B. N.; Patel, K. R.; Begum, R.; Patel, P. S., Sialylation: an avenue to target cancer cells. Pathology & Oncology Research 2016, 22 (3), 443-447.
62. Bhide, G. P.; Colley, K. J., Sialylation of N-glycans: mechanism, cellular compartmentalization and function. Histochemistry and cell biology 2017, 147 (2), 149-174.
63. Szabo, R.; Skropeta, D., Advancement of sialyltransferase inhibitors: therapeutic challenges and opportunities. Medicinal research reviews 2017, 37 (2), 219-270.
64. Ma, X.; Dong, W.; Su, Z.; Zhao, L.; Miao, Y.; Li, N.; Zhou, H.; Jia, L., Functional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8SIA4. Cell death & disease 2016, 7 (12), e2561.
65. Li, Y.; Chen, X., Sialic acid metabolism and sialyltransferases: natural functions and applications. Applied microbiology and biotechnology 2012, 94 (4), 887-905.
66. Whitehouse, C.; Burchell, J.; Gschmeissner, S.; Brockhausen, I.; Lloyd, K. O.; Taylor-Papadimitriou, J., A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2–based O-glycans. The Journal of cell biology 1997, 137 (6), 1229-1241.
67. Kessel, D.; Allen, J., Elevated plasma sialyltransferase in the cancer patient. Cancer research 1975, 35 (3), 670-672.
68. Lee, Y. T. N.; Tokes, Z. A.; Csipke, C. P., Plasma sialyltransferase in patients with breast cancer. Journal of surgical oncology 1980, 14 (2), 159-165.
69. Picco, G.; Julien, S.; Brockhausen, I.; Beatson, R.; Antonopoulos, A.; Haslam, S.; Mandel, U.; Dell, A.; Pinder, S.; Taylor-Papadimitriou, J., Over-expression of ST3Gal-I promotes mammary tumorigenesis. Glycobiology 2010, 20 (10), 1241-1250.
70. Dufner, G.; Schwörer, R.; Müller, B.; Schmidt, R. R., Base‐and Sugar‐Modified Cytidine Monophosphate N‐Acetylneuraminic Acid (CMP‐Neu5Ac) Analogues‐Synthesis and Studies with α (2‐6)‐Sialyltransferase from Rat Liver. European Journal of Organic Chemistry 2000, 2000 (8), 1467-1482.
71. Klohs, W. D.; Bernacki, R. J.; Korytnyk, W., Effects of nucleotides and nucleotide: analogs on human serum sialyltransferase. Cancer research 1979, 39 (4), 1231-1238.
72. Lee, L.; Chang, K. H.; Valiyev, F.; Liu, H. J.; Li, W. S., Synthesis and biological evaluation of 5′‐triazole nucleosides. Journal of the Chinese Chemical Society 2006, 53 (6), 1547-1555.
73. Wu, C.-Y.; Hsu, C.-C.; Chen, S.-T.; Tsai, Y.-C., Soyasaponin I, a potent and specific sialyltransferase inhibitor. Biochemical and biophysical research communications 2001, 284 (2), 466-469.
74. Chang, K.-H.; Lee, L.; Chen, J.; Li, W.-S., Lithocholic acid analogues, new and potent α-2, 3-sialyltransferase inhibitors. Chemical Communications 2006, (6), 629-631.
75. Chen, J.-Y.; Tang, Y.-A.; Huang, S.-M.; Juan, H.-F.; Wu, L.-W.; Sun, Y.-C.; Wang, S.-C.; Wu, K.-W.; Balraj, G.; Chang, T.-T., A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways. Cancer research 2011.
76. Chiang, C. H.; Wang, C. H.; Chang, H. C.; More, S. V.; Li, W. S.; Hung, W. C., A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin‐mediated signaling. Journal of cellular physiology 2010, 223 (2), 492-499.
77. Hinou, H.; Sun, X.-L.; Ito, Y., Systematic syntheses and inhibitory activities of bisubstrate-type inhibitors of sialyltransferases. The Journal of organic chemistry 2003, 68 (14), 5602-5613.
78. Hinou, H.; Sun, X.-L.; Ito, Y., Bisubstrate-type inhibitor of sialyltransferases. Tetrahedron letters 2002, 43 (50), 9147-9150.
79. Izumi, M.; Wada, K.; Yuasa, H.; Hashimoto, H., Synthesis of bisubstrate and donor analogues of sialyltransferase and their inhibitory activities. The Journal of organic chemistry 2005, 70 (22), 8817-8824.
80. Izumi, M.; Yuasa, H.; Hashimoto, H., Bisubstrate analogues as glycosyltransferase inhibitors. Current topics in medicinal chemistry 2009, 9 (1), 87-105.
81. Lavogina, D.; Enkvist, E.; Uri, A., Bisubstrate inhibitors of protein kinases: from principle to practical applications. ChemMedChem: Chemistry Enabling Drug Discovery 2010, 5 (1), 23-34.
82. Vardanyan, R.; Kumirov, V. K.; Nichol, G. S.; Davis, P.; Liktor-Busa, E.; Rankin, D.; Varga, E.; Vanderah, T.; Porreca, F.; Lai, J., Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands. Bioorganic & medicinal chemistry 2011, 19 (20), 6135-6142.
83. Cruz, F. F.; Rocco, P. R. M.; Pelosi, P., Anti-inflammatory properties of anesthetic agents. Critical Care 2017, 21 (1), 67.
84. Coussens, L. M.; Werb, Z., Inflammation and cancer. Nature 2002, 420 (6917), 860.
85. Rayburn, E. R.; Ezell, S. J.; Zhang, R., Anti-inflammatory agents for cancer therapy. Molecular and cellular pharmacology 2009, 1 (1), 29.
86. Henke, J.; Haberstroh, B. J.; Freiburg Martin Sager, D., Expert Information. |